Evidence review
Labs and Monitoring on GLP-1: What Women Should Ask For
A women's-health guide to labs and monitoring on GLP-1: which markers matter, why oversight counts, and what to ask a provider to track.
Why monitoring matters more for women
Good GLP-1 care is not a vial in the mail — it is a plan for watching how your body responds. For women, that plan carries extra weight because metabolic and hormonal pictures overlap: insulin resistance, thyroid function, and where you are in the menstrual or menopause transition all shape treatment3. Monitoring is how a clinician catches what needs adjusting and confirms treatment is helping the metabolic problem, not just moving the scale. This guide is a starting point for that conversation, not medical advice, and the exact tests are your clinician's call.
Baseline markers worth discussing
Before or around starting, it is reasonable to ask what baseline your provider will establish. Metabolic markers such as fasting glucose and HbA1c reflect the insulin-resistance picture these medicines act on — the same machinery behind much of PCOS weight4. Many programs also look at a lipid panel and, given how often thyroid issues sit alongside metabolic ones in women, thyroid function. A baseline is what makes later results meaningful; without it, "it's working" is guesswork.
What to track over time
As you titrate, follow-up matters: repeating the metabolic markers shows whether insulin sensitivity is improving, not just whether weight is falling1. Because GLP-1 treatment changes appetite and intake, a clinician may also keep an eye on how you are eating and tolerating the dose. And for women specifically, the picture includes contraception and pregnancy planning — these medicines are not used in pregnancy — which belongs in every check-in, not only at signup.
Turning labs into a provider question
You do not need to memorize a panel — you need a provider that runs and interprets one. When comparing programs, ask plainly: what do you check at baseline, what do you re-check over time, and who reviews the results? A program that includes real monitoring is doing metabolic care; one that skips it is selling a prescription. That distinction is exactly what our Luna Fit Score methodology rewards. Pair this with our provider-choice checklist, the insulin resistance guide, and the PCOS guide, and bring the questions to a clinician who can see your whole picture.
Frequently asked questions
What labs should I ask for on a GLP-1?
Ask your clinician about a baseline that may include fasting glucose and HbA1c, a lipid panel, and — given how often it overlaps in women — thyroid function, then follow-up testing over time. The exact panel is your clinician's decision.
Why does monitoring matter if I'm just losing weight?
Follow-up labs show whether insulin sensitivity is actually improving, not only whether the scale is moving. For women, monitoring also keeps thyroid, contraception and pregnancy planning in view — which is what real metabolic care looks like.
References
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2032183
- U.S. Food and Drug Administration (2023). Wegovy (semaglutide) injection — prescribing information. FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf
- Endocrine Society (2022). Polycystic Ovary Syndrome — Endocrine Library. Endocrine Society. https://www.endocrine.org/patient-engagement/endocrine-library/pcos
- American College of Obstetricians and Gynecologists (2023). Polycystic Ovary Syndrome (PCOS): patient FAQ. ACOG. https://www.acog.org/womens-health/faqs/polycystic-ovary-syndrome-pcos
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
GLP-1 Medication and PCOS: What Women Should Know
How GLP-1 medicines target the insulin resistance behind PCOS weight — and the questions to ask a provider about tirzepatide, labs and androgens.
ReadGLP-1 Care Through Perimenopause and Menopause
The midlife metabolic shift is real. How GLP-1 medicines fit alongside the hormonal changes of the menopause transition — and what to weigh.
ReadGLP-1 Medicines, Your Cycle, and Contraception
Appetite, the menstrual cycle, birth control absorption and pregnancy — the women's-specific questions worth raising before you start a GLP-1.
ReadHow to Choose a GLP-1 Provider as a Woman
A women's-health checklist for picking a GLP-1 provider: hormonal suitability, labs, clinical oversight and price — not just the cheapest vial.
ReadCompounded vs Brand-Name GLP-1 for Women
What the compounded-vs-brand choice really means for women: what the evidence covers, what compounding is, and how to decide with a clinician.
ReadSemaglutide vs Tirzepatide for Women: Insulin Resistance and Results
How semaglutide and tirzepatide compare for women — mechanism, weight-loss results and why insulin resistance shapes the choice.
ReadGLP-1 and Insulin Resistance: Why It Matters for Women
The metabolic mechanism behind stubborn weight in women — how insulin resistance works and where GLP-1 medicines act on it.
ReadWhat GLP-1 Costs and How to Start Safely
A measured women's-lens look at GLP-1 cost and starting safely: 503A vs 503B pharmacies, LegitScript, FDA compounding and what to verify.
Read